-+ 0.00%
-+ 0.00%
-+ 0.00%

SHARES OF MILESTONE PHARMACEUTICALS UP 34.8% PREMARKET AFTER FDA APPROVES CO'S HEART RHYTHM NASAL SPRAY

Reuters·12/15/2025 13:05:28

Please log in to view news